Development of an identity test for COVID-19 mRNA vaccines using SARS-CoV-2 NAT standard
{{output}}
Despite the development of messenger ribonucleic acid (mRNA) vaccines for the infectious novel coronavirus 2 (SARS-CoV-2), further research on test methods is required to ensure their quality as well as rapid and effective approval for release to the market. D... ...
